<http://mountaingroup.wpengine.com/#organization>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>
<http://schema.org/Organization>
<https://mtngp.com/g1-therapeutics-announces-positive-trilaciclib-phase-2a-topline-data-showing-robust-myelopreservation-bene-ts-patients-small-cell-lung-cancer/>